Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AF37702 Injection vs epoetin beta for maintenance treatment of anemia in hemodialysis patients
2007-004153-28Phase 3Completed
- Sponsor
- Affymax, Inc.
- Start
- Dec 2007
- Modality
- Peptides, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of peginesatide in anemia of renal disease (2 arms), sponsored by Affymax, Inc. Primary endpoint: Mean change in hemoglobin from baseline to evaluation period. Started Dec 2007; status: completed.
02
Drugs
peginesatide
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on 2007-004153-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004153-28.